This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why You Should Keep Aflac (AFL) in Your Portfolio Now
by Zacks Equity Research
Aflac (AFL) is expected to gain heavily from its global investment expanding moves.
Unum (UNM) Up 5.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Unum (UNM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Aflac (AFL) Up 2.4% Since Last Earnings Report?
by Zacks Equity Research
Aflac (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aflac (AFL) Adds Mental Health Coverage to Up Insurance Product
by Zacks Equity Research
Aflac (AFL) launches an enhanced version of its Individual Short-Term Disability product and extends mental health coverage to offer peace of mind to employees.
CNO Financial (CNO) Up 2% on Q2 Earnings Beat on Lower Costs
by Zacks Equity Research
CNO Financial's (CNO) second-quarter results reflect a solid variable investment income, higher annuity collected premiums and a fall in benefits and expenses.
RenaissanceRe (RNR) Stock Down 11% Despite Q2 Earnings Beat
by Zacks Equity Research
RenaissanceRe's (RNR) second-quarter results reflect rate increases and strong underwriting results at the Casualty and Specialty segment, partly offset by high expenses.
Aflac (AFL) Q2 Earnings Beat on Strong U.S. Business, Lower Costs
by Zacks Equity Research
Aflac's (AFL) second-quarter results benefit from increased sales in its U.S. business and lower expenses, partly offset by softness in the Japan business.
Aflac (AFL) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of 13.18% and 12.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) to Announce Q2 Earnings: Here's What to Expect
by Zacks Equity Research
Aflac's (AFL) second-quarter results are likely to reflect a decline in total net earned premiums.
Amerisafe (AMSF) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of 15.25% and 8.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Aflac (AFL) closed at $56.42, marking a +0.75% move from the previous day.
Aflac Q2 Preview: Can the Earnings Streak Continue?
by Derek Lewis
Aflac has been on a blazing-hot earnings streak, exceeding the Zacks Consensus Estimate in 21 consecutive quarters.
Analysts Estimate Unum (UNM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Unum (UNM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Aflac (AFL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Aflac (AFL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aflac (AFL) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Aflac (AFL) closed at $55.28 in the latest trading session, marking a +0.45% move from the prior day.
Aflac (AFL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aflac (AFL) closed at $54.31 in the latest trading session, marking a +1.61% move from the prior day.
Zacks Industry Outlook Highlights Aflac, Unum, and Amerisafe
by Zacks Equity Research
Aflac, Unum, and Amerisafe are part of Zacks Industry Outlook article.
3 Stocks to Watch From the Prospering Accident & Health Insurance Industry
by Tanuka De
Higher claims frequency leading to upward pricing pressure, coupled with the adoption of technology, is likely to boost the performance of Zacks Accident and Health Insurance industry insurance players like AFL, UNM, and AMSF.
Aflac (AFL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aflac (AFL) closed the most recent trading day at $53.05, moving +0.08% from the previous trading session.
Aflac (AFL) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Aflac (AFL) closed at $58.72, marking a -1.53% move from the previous day.
Aflac (AFL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aflac (AFL) closed at $59.69, marking a -0.2% move from the previous day.
Why Is Aflac (AFL) Down 0.2% Since Last Earnings Report?
by Zacks Equity Research
Aflac (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insurance ETFs to Gain on Solid Q1 Earnings
by Sweta Killa
Take a look at insurance ETFs post Q1 earnings.
Aflac (AFL) Q1 Earnings Beat on Higher US Sales, Lower Costs
by Zacks Equity Research
Aflac (AFL) expects sales in Japan to improve in the second half of 2022.
Aflac (AFL) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of 2.90% and 2.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?